CD79A and COVID-19: This study aims to assess the kinetics of IgG, IgM and IgA antibodies up to 12 months post-infection in a large cohort of COVID-19 patients in Africa, and to analyze the impact of host factors such as age, sex and comorbidities on antibody levels during this period.